3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
18
Phase 2
12
Phase 1
6
Phase 3
4
Phase EARLY_PHASE1
3
Phase 4
3
Phase 2/3
1
Phase 1/2
1
Status
Completed
8
Recruiting
5
Unknown
3
Active not recruiting
3
Terminated
2
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
30
Other hematologic neoplasm
10
Thoracic
9
Breast
7
Genitourinary
6
Lymphoid
5
Head & Neck
5
Gynecologic
5
CNS
4
Tumor-Agnostic
3
Plasma cell
3
Myeloid
2
Sarcoma
1
Other neoplasm
1
Endocrine
1
Dermatologic
1
Conditions
Thyroid Carcinoma, Anaplastic
1
Thyroid Cancer, Papillary
1
Ovarian Neoplasms
1
Neoplasms by Site
1
Neoplasms by Histologic Type
1
Neoplasms
1
Multiple Myeloma
1
Lymphoproliferative Disorders
1
Laryngeal Neoplasms
1
Histiocytosis, Langerhans-Cell
1
Hematologic Neoplasms
1
Glioma
1
Gastrointestinal Neoplasms
1
Erdheim-Chester Disease
1
Colorectal Neoplasms
1
Carcinoma, Non-Small-Cell Lung
1
Interventions
trametinib
1
dabrafenib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2/3
×
Not yet recruiting
×
Endocrine
×
Clear all
NCT07440290
2026-02-27
DETERMINE
Cancer Research UK
Phase 2/3
Not yet recruiting
30 enrolled